Terms: = Prostate cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1
100 results:
1. Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity.
Ronchi S; Cicchetti A; Bonora M; Ingargiola R; Camarda AM; Russo S; Imparato S; Castelnuovo P; Pasquini E; Nicolai P; Ansarin M; Del Vecchio M; Benazzo M; Orlandi E; Vischioni B
Radiother Oncol; 2024 Jan; 190():110003. PubMed ID: 37956889
[TBL] [Abstract] [Full Text] [Related]
2. MRI characteristics and oncological follow-up of patients with ISUP grade group 4 or 5 prostate cancer.
Boschheidgen M; Schimmöller L; Kastl R; Drewes LR; Jannusch K; Radke KL; Kirchner J; Ullrich T; Niegisch G; Albers P; Antoch G; Radtke JP
Abdom Radiol (NY); 2024 Jan; 49(1):192-201. PubMed ID: 37906272
[TBL] [Abstract] [Full Text] [Related]
3. Effect of Socioeconomic Disparities on Suicide Risk in Patients With prostate cancer During 2005 to 2020: A Population Study.
Jia YJ; Hu FH; Tang W; Zhang WQ; Ge MW; Shen LT; Hu SQ; Shen WQ; Chen HL
Clin Genitourin Cancer; 2024 Apr; 22(2):84-91.e7. PubMed ID: 37758561
[TBL] [Abstract] [Full Text] [Related]
4. Characterization of metabolism-associated molecular patterns in prostate cancer.
Yang B; Jiang Y; Yang J; Zhou W; Yang T; Zhang R; Xu J; Guo H
BMC Urol; 2023 Jun; 23(1):104. PubMed ID: 37280589
[TBL] [Abstract] [Full Text] [Related]
5. Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients.
Oh JH; Lee S; Thor M; Rosenstein BS; Tannenbaum A; Kerns S; Deasy JO
Radiother Oncol; 2023 Aug; 185():109723. PubMed ID: 37244355
[TBL] [Abstract] [Full Text] [Related]
6. Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study.
Jochems SHJ; Fritz J; Häggström C; Stattin P; Stocks T
Cancer Med; 2023 Jun; 12(12):13732-13744. PubMed ID: 37102250
[TBL] [Abstract] [Full Text] [Related]
7. Surgeon volume and patient-reported urinary incontinence after radical prostatectomy. Population-based register study in Sweden.
Arnsrud Godtman R; Persson E; Bergengren O; Carlsson S; Johansson E; Robinsson D; Hugosson J; Stattin P
Scand J Urol; 2022; 56(5-6):343-350. PubMed ID: 36068973
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive analysis of emerging flame retardants, a risk factor to prostate cancer?
Liu S; He B; Li H
Ecotoxicol Environ Saf; 2022 Jul; 239():113627. PubMed ID: 35588625
[TBL] [Abstract] [Full Text] [Related]
9. Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer.
Tsumura H; Tanaka N; Oguchi T; Owari T; Nakai Y; Asakawa I; Iijima K; Kato H; Hashida I; Tabata KI; Satoh T; Ishiyama H
Radiat Oncol; 2022 Apr; 17(1):71. PubMed ID: 35410307
[TBL] [Abstract] [Full Text] [Related]
10. Associations between long-term exposure to PM
Yu P; Xu R; Li S; Coelho MSZS; Saldiva PHN; Sim MR; Abramson MJ; Guo Y
Environ Pollut; 2022 Jun; 302():119070. PubMed ID: 35231538
[TBL] [Abstract] [Full Text] [Related]
11. Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015-2016.
Nilssen Y; Brustugun OT; Eriksen MT; Guren MG; Haug ES; Naume B; Schlichting E; Møller B
BMC Cancer; 2022 Feb; 22(1):220. PubMed ID: 35227226
[TBL] [Abstract] [Full Text] [Related]
12. Bipolar Electrode Array for Multiplexed Detection of prostate cancer Biomarkers.
Liu Y; Zhang N; Pan JB; Song J; Zhao W; Chen HY; Xu JJ
Anal Chem; 2022 Feb; 94(6):3005-3012. PubMed ID: 35103469
[TBL] [Abstract] [Full Text] [Related]
13. Development and Validation of an Improved Pathological Nodal Staging System in Men with prostate cancer.
Daskivich TJ; Luu M; Freedland SJ; Sandler H; Spratt DE; Zumsteg ZS
J Urol; 2022 Mar; 207(3):581-591. PubMed ID: 34694160
[TBL] [Abstract] [Full Text] [Related]
14. Seasonal variations in the diagnosis of the top 10 cancers in Korea: A nationwide population-based study using a common data model.
Yoon JY; Kwak MS; Kim HI; Cha JM
J Gastroenterol Hepatol; 2021 Dec; 36(12):3371-3380. PubMed ID: 34293206
[TBL] [Abstract] [Full Text] [Related]
15. Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment.
Grechko N; Skarbova V; Tomaszewska-Kiecana M; Ramlau R; Centkowski P; Drew Y; Dziadziuszko R; Zemanova M; Beltman J; Nash E; Habeck J; Liao M; Xiao J
Cancer Chemother Pharmacol; 2021 Aug; 88(2):259-270. PubMed ID: 33909097
[TBL] [Abstract] [Full Text] [Related]
16. Serum core-type fucosylated prostate-specific antigen index for the detection of high-risk prostate cancer.
Fujita K; Hatano K; Tomiyama E; Hayashi Y; Matsushita M; Tsuchiya M; Yoshikawa T; Date M; Miyoshi E; Nonomura N
Int J Cancer; 2021 Jun; 148(12):3111-3118. PubMed ID: 33594666
[TBL] [Abstract] [Full Text] [Related]
17. Differences in Use of Aggressive Therapy for Localized prostate cancer in New York City.
Smigelski M; Wallace BK; Lu J; Li G; Anderson CB
Clin Genitourin Cancer; 2021 Feb; 19(1):e55-e62. PubMed ID: 32891565
[TBL] [Abstract] [Full Text] [Related]
18. Trends in cancer incidence and survival in the Augsburg study region-results from the Augsburg cancer registry.
Grundmann N; Meisinger C; Trepel M; Müller-Nordhorn J; Schenkirsch G; Linseisen J
BMJ Open; 2020 Aug; 10(8):e036176. PubMed ID: 32868355
[TBL] [Abstract] [Full Text] [Related]
19. cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications.
Bernatsky S; Ramsey-Goldman R; Urowitz MB; Hanly JG; Gordon C; Petri MA; Ginzler EM; Wallace DJ; Bae SC; Romero-Diaz J; Dooley MA; Peschken CA; Isenberg DA; Rahman A; Manzi S; Jacobsen S; Lim SS; van Vollenhoven R; Nived O; Kamen DL; Aranow C; Ruiz-Irastorza G; Sánchez-Guerrero J; Gladman DD; Fortin PR; Alarcón GS; Merrill JT; Kalunian KC; Ramos-Casals M; Steinsson K; Zoma A; Askanase A; Khamashta MA; Bruce I; Inanc M; Clarke AE
Arthritis Care Res (Hoboken); 2021 Dec; 73(12):1789-1795. PubMed ID: 32813314
[TBL] [Abstract] [Full Text] [Related]
20. Deep learning applications in automatic needle segmentation in ultrasound-guided prostate brachytherapy.
Wang F; Xing L; Bagshaw H; Buyyounouski M; Han B
Med Phys; 2020 Sep; 47(9):3797-3805. PubMed ID: 32542758
[TBL] [Abstract] [Full Text] [Related]
[Next]
